2007

1. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

   Oncology Reports, Vol. 17, Núm. 2, pp. 325-328